Product Reports Resources Pricing Login Book a demo

CPTx

Biotech & Life Sciences · Planegg, Germany · Founded 2021

At CPTx, new treatment paradigms are developed to address unmet medical challenges, with an initial focus on infectious diseases MoreLess

CPTx is a pioneering biotechnology company dedicated to developing innovative treatment paradigms for unmet medical challenges, with an initial focus on infectious diseases. Our mission is to revolutionize the way these conditions are treated, improving patient outcomes and addressing critical global health needs.

At CPTx, we leverage cutting-edge science and technology to identify and advance novel therapeutic approaches. Our interdisciplinary team of scientists, researchers, and industry experts is committed to pushing the boundaries of medical innovation to create effective and accessible treatments for patients worldwide.

Our primary focus is on infectious diseases, which continue to pose significant threats to public health. By targeting these diseases, we aim to develop new therapies that can combat drug resistance, enhance treatment efficacy, and reduce the burden of infection. Our research and development efforts are guided by a deep understanding of disease mechanisms and a commitment to rigorous scientific inquiry.

CPTx's innovative approach includes the exploration of new molecular targets, the development of advanced drug delivery systems, and the application of state-of-the-art diagnostic tools. We collaborate with leading academic institutions, research organizations, and industry partners to accelerate the translation of our discoveries into clinical applications.

In addition to our focus on infectious diseases, CPTx is committed to addressing other unmet medical needs. Our platform technologies and scientific expertise enable us to explore a wide range of therapeutic areas, from rare diseases to chronic conditions. By pursuing a multi-faceted approach, we aim to create a diverse pipeline of innovative treatments that can transform patient care.

At CPTx, we are driven by a passion for improving lives and a dedication to scientific excellence. Our commitment to ethical and responsible research ensures that our solutions are developed with the well-being of patients and the broader community in mind.

Company overview

CPTx company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2021
Headquarters
Planegg, Germany
Employees
49
Open positions
None listed
Dealroom signal
84.9
client focusb2bsub industryPharmaceuticalsub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorDrug DevelopmentsectorDNAsectorInfections and Infectious DiseasessectorGenetics and genomicssectorGene TherapysectorDiseasesectorBiotech and PharmasectorDT and LS

Valuation & funding

CPTx funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCEquity / VC Sep 2024 $29M $116M Andrej Henkler · Bayern Kapital · Stefan Oschmann · BlueYard Capital
SEEDEquity / VC Feb 2024 BlueYard Capital
Showing 2 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 49
2025 43
2024 34
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

CPTx website traffic

Latest recorded traffic for CPTx is 2.6K monthly website visits, up 160% over the last three months. CPTx's team grew 14% over the past year.

Latest monthly visits2.6K 3-month web change+160% 1-year team growth+14%
Monthly website visits16 observations · Apr 2025–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

CPTx compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

CPTx's talent

Book a demo to see the people
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on CPTx's cap table

Sourced from Dealroom's funding and investor records.

Seed 1 investor entered at this stage
BlueYard Capital
Series A 4 investors entered at this stage
SPRIN-D
Andrej Henkler
Bayern Kapital
Stefan Oschmann
Other known 1 additional known investor
Leblon Capital

Global footprint

Where CPTx has talent and traffic

Workforce by country
4 countries with
team presence
🇩🇪 Germany88.6%
🇺🇸 United States5.7%
🇨🇦 Canada2.9%
🇨🇭 Switzerland2.9%
4 countries shown

In the news

Latest news about CPTx

Recent press, funding announcements, and product moves mentioning CPTx — open to read from the original sources.

See all news

Market sentiment

What the market is saying about CPTx

An AI-synthesized read of the highest-engagement posts about CPTx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CPTx’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.